CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling.
about
Islet inflammation: a unifying target for diabetes treatment?Transcriptional regulation of chemokine genes: a link to pancreatic islet inflammation?Identification of Novel Type 1 Diabetes Candidate Genes by Integrating Genome-Wide Association Data, Protein-Protein Interactions, and Human Pancreatic Islet Gene ExpressionThe unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice.Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in miceTLR4 and Insulin Resistance.Protein kinase C delta (PKCδ) affects proliferation of insulin-secreting cells by promoting nuclear extrusion of the cell cycle inhibitor p21Cip1/WAF1.COUP-TFII controls mouse pancreatic β-cell mass through GLP-1-β-catenin signaling pathwaysTranscription of the gene encoding TNF-α is increased by IL-1β in rat and human islets and β-cell linesAdipose tissue remodeling as homeostatic inflammation.Lipopolysaccharides impair insulin gene expression in isolated islets of Langerhans via Toll-Like Receptor-4 and NF-κB signalling.CXC chemokine ligand 10 DNA vaccination plus Complete Freund's Adjuvant reverses hyperglycemia in non-obese diabetic mice.Bimodal effect on pancreatic β-cells of secretory products from normal or insulin-resistant human skeletal muscleInduction of an inflammatory loop by interleukin-1β and tumor necrosis factor-α involves NF-kB and STAT-1 in differentiated human neuroprogenitor cells.Neutralizing interleukin-1beta (IL-1beta) induces beta-cell survival by maintaining PDX1 protein nuclear localization.Toll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice.Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease.CCL20 is elevated during obesity and differentially regulated by NF-κB subunits in pancreatic β-cells.Expression and regulation of chemokines in murine and human type 1 diabetes.Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes.Effect of CXCL10 receptor antagonist on islet cell apoptosis in a type I diabetes rat model.Back From the Brink: The Uses of Targeting the CXCL10:CXCR3 Axis in Type 1 DiabetesFunctional redundancy of CXCR3/CXCL10 signaling in the recruitment of diabetogenic cytotoxic T lymphocytes to pancreatic islets in a virally induced autoimmune diabetes modelCXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic SteatohepatitisTOSO promotes β-cell proliferation and protects from apoptosis.Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survivalExpression of toll-like receptor 4 in maternal monocytes of patients with gestational diabetes mellitus.Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?β-MSCs: successful fusion of MSCs with β-cells results in a β-cell like phenotype.Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study.The role of the CXCL10/CXCR3 system in type 1 diabetes.MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes.Siglec-7 restores β-cell function and survival and reduces inflammation in pancreatic islets from patients with diabetes.Bimodal impact of skeletal muscle on pancreatic β-cell function in health and disease.Toll-like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes.Toll-Like Receptor Activation in Immunity vs. Tolerance in Autoimmune Diabetes.Androgen receptor-deficient islet β-cells exhibit alteration in genetic markers of insulin secretion and inflammation. A transcriptome analysis in the male mouse.Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-beta-1b treatment in relapsing remitting MS.High Risk First Degree Relatives of Type 1 Diabetics: An Association with Increases in CXCR3(+) T Memory Cells Reflecting an Enhanced Activity of Th1 Autoimmune Response.Impact of Systemic Inflammation on the Progression of Gestational Diabetes Mellitus.
P2860
Q26860847-FDFC5C36-5031-4B37-80DB-724DD28E18BCQ27009030-CF1E1F12-C6FA-47A9-B21C-2300D2975C40Q30002303-FEEAE78E-43A4-43DA-8755-0B7580AE96D2Q30435990-94A8B350-5A3F-47BA-861C-4148ED0F4A9BQ33687009-8D694D41-6A00-48A3-8269-8E5FDC8AD271Q34097407-58C3192C-DEDE-42B8-826D-4B09C85EBB5AQ34116998-FAA9B709-8D89-4E40-A302-41035F85E26BQ34146466-15EC99B1-D588-49B5-A55C-869E9981ADACQ34146626-4940B870-D918-4239-BE41-EBA02F83EA87Q34200313-2431F31C-B846-4810-9065-DA228433AA2AQ34257301-C7030B3C-5D1B-4CCA-AA4F-6F4C7A4F8587Q34703152-18A0CE9D-19CF-4BCA-8E44-3B88C9E88041Q34718673-F86D5F17-EB15-41CC-B404-BE83BAECEDB7Q34903095-77147762-5320-43F6-8EB5-0EEF1189A6D0Q34948047-905B3604-2AA3-4C4F-97C3-32D1C52484CAQ35005601-F978C914-EA53-49C5-A193-8B2BEA041E85Q35591165-8770B37E-6163-4770-9EA8-18B46018D25AQ35625034-5C665EA2-9016-4685-9E71-9D68DD0B1609Q35696643-A4D4270A-6FFF-4A8D-BE95-B0A2E6ECA615Q36129739-D8F22646-DA38-4BC1-9774-B91EE858073CQ36464500-004A92B6-288F-43A0-8524-779C564AEBF3Q36926382-009BFA5D-8396-4C19-804A-99FBF2F212FBQ37014873-0424ECA2-61FF-4BE9-9EBB-13CB4B1484F4Q37044406-5E2C1BBB-909B-4961-A9F9-75685AAB5288Q37133402-E7136506-F8C2-46EC-9612-5D091E24CB7DQ37259981-5BBF6EA9-1A53-4DFD-8468-A9810A83DC4AQ37388603-82716B87-109D-472B-B77E-2100FD9BAC3AQ37470376-4F84F587-2E3E-4DF0-B73C-29611E989CF5Q37580150-B164E5C3-09C0-4CBD-8B5C-A1AF7235F246Q37600224-392D9CE9-B09B-4AC2-B255-4A6E6D5EC2B4Q37608933-168755B5-02EE-44E0-9D1E-B944528673C8Q37694711-7899FC64-74D8-48CB-8A38-8A2A7A9CD9D5Q37738267-79B86774-9517-4AC2-9DD0-C5E6474FC761Q38038654-D51ABC71-5D52-4E2C-8A99-E9BC407CCA86Q38184888-66673C02-D0C3-4D42-9E25-33BC9F8BF10DQ38203260-65E9A001-D5E8-429E-8FB1-299ED666ABD4Q38435447-7AFB5BE3-30ED-47AE-BD9F-B0C82C8F8E45Q38507467-CD6E965B-8E32-41CB-9EE9-DC8FB5E88F8AQ38652301-951AEF53-3546-4E33-B0D5-B67B5931289FQ38734509-08FED552-BBBA-47AA-A483-88D10D794F30
P2860
CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling.
@en
CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling.
@nl
type
label
CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling.
@en
CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling.
@nl
prefLabel
CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling.
@en
CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling.
@nl
P2093
P1433
P1476
CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling.
@en
P2093
Charles C King
Fabienne T Schulthess
Federico Paroni
Jose Oberholzer
Kathrin Maedler
Leena Haataja
Nadine S Sauter
Pascale Ribaux
Robert M Strieter
P304
P356
10.1016/J.CMET.2009.01.003
P577
2009-02-01T00:00:00Z